Sidewinder Therapeutics
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9880 Campus Point Dr Ste 360, San Diego,...Website
www.sidewinderbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
1
1
1
1
About Sidewinder Therapeutics
Sidewinder Bio is a clinical-stage biotechnology company focused on developing next-generation precision cancer therapies, particularly bispecific antibody-drug conjugates designed to selectively target and destroy tumor cells while minimizing damage to healthy tissue. The company uses advanced antibody engineering and drug-linker technologies to improve tumor targeting, cellular uptake, and treatment safety, aiming to create more effective and better-tolerated oncology treatments. Based in the United States, Sidewinder Bio is working on early-stage drug candidates and preclinical programs intended to advance into clinical development for solid tumor cancers.Explore more
Sidewinder Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sidewinder Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Sidewinder Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Sidewinder Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sidewinder Therapeutics
Funding: Get notified immidiatlly once Sidewinder Therapeutics has new funding data
Click to see if Sidewinder Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Sidewinder Therapeutics launches new products
Check out if Sidewinder Therapeutics is spiking on competitors!
Check if Sidewinder Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Sidewinder Therapeutics
Find 3 more new buyers
Compare Similar Companies to Sidewinder Therapeutics
Compare insights from companies similar to Sidewinder Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sidewinder Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sidewinder Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sidewinder Therapeutics.
Sidewinder Therapeutics financials insights
Gather financial insights about Sidewinder Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$23M
2026
Series B
$137M
Sidewinder Therapeutics Tech Stack
A closer look at the technologies used by Sidewinder Therapeutics
See more technologies
Sidewinder Therapeutics News & Media
Sidewinder Therapeutics Inks $137M Series B Financing
SAN DIEGO, CA, Sidewinder Therapeutics, a biopharmaceutical company, announced the closing of an oversubscribed $137 million Series B financing.Sidewinder pockets $137m in Series B to take bispecific ADCs to clinic
The funding round, led by Novartis and OrbiMed, will allow Sidewinder to progress its bispecific ADC programmes to the clinic.Lonza's Synaffix and Sidewinder Therapeutics Announce Multi-Target License Agreement to Advance Development of Next-Generation Bispecific ADCs
Multi-target license agreement grants Sidewinder access to Lonza's clinically validated ADC platform Sidewinder's pipeline of precision bispecific ADCs combined with Lonza's clinically validated ADC platform will enable the development of first-in-class bispecific ADCs with enhanced...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Sidewinder Therapeutics
Sign Up For FreeTo access detailed company insights
Sidewinder Bio is a clinical-stage biotechnology company focused on developing next-generation precision cancer therapies, particularly bispecific antibody-drug conjugates designed to selectively target and destroy tumor cells while minimizing damage to healthy tissue. The company uses advanced antibody engineering and drug-linker technologies to i... Read More
